Connect with us
DAPA Banner
DAPA Coin
DAPA
COIN PAYMENT ASSET
PRIVACY · BLOCKDAG · HOMOMORPHIC ENCRYPTION · RUST
ElGamal Encrypted MINE DAPA
🚫 GENESIS SOLD OUT
DAPAPAY COMING

Business

Botanix Pharmaceuticals Limited (BXPHF) Discusses Quarterly Activity, Cash Flow, and Commercial Progress of Sofdra for Primary Axillary Hyperhidrosis Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Jane Morgan

Good morning, everyone, and thank you for joining today’s investor webinar for Botanix Pharmaceuticals with the ASX ticket code BOT. My name is Jane Morgan, the Investor and Media Relations Manager. And today, I am joined by our Executive Chairman, Vincent Ippolito, our CEO, Dr. Howie McKibbon; and our U.S. CFO, Chris Lesovitz.

So for those who are new to the Botanix story, Botanix is a commercial stage dermatology company operating in Australia and the United States with this FDA-approved product Sofdra, which is available in America. Sofdra is a prescription-only topical gel medicine, which used to treat excessive underarm sweating or more formally known as primary axillary hyperhidrosis. It is used in treating adults and children aged 9 and over.

The company has transitioned from a development stage business into a revenue-generating commercial entity with Sofdra as its primary growth driver. Today’s presentation will be followed by a Q&A session. [Operator Instructions]

Advertisement

Vince, I’m going to hand to you.

Vincent Ippolito
MD & Executive Chairman

Thank you, Jane, and a pleasant good morning to everyone here joining us from Australia. Dr. Howie McKibbon and myself are here live in Sydney for this call. Chris Lesovitz is calling in from our headquarters in the U.S. and we’re pleased to present the Botanix Quarterly Activity Report and 4C Quarterly Cash Flow Report for the period ending 30 June 2026. And the company has come a long way since our highly successful commercial launch of Sofdra a little over a year ago, and we’re very pleased with

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Ares Capital's Fat Yield Makes It Worth Keeping

Published

on

Ares Capital's Fat Yield Makes It Worth Keeping

Ares Capital's Fat Yield Makes It Worth Keeping

Continue Reading

Business

Esquire Financial: Earnings Accelerate Ahead Of Deal Completion

Published

on

Esquire Financial: Earnings Accelerate Ahead Of Deal Completion

Esquire Financial: Earnings Accelerate Ahead Of Deal Completion

Continue Reading

Business

SL Green: Struggling To Get Along

Published

on

SL Green: Struggling To Get Along

SL Green: Struggling To Get Along

Continue Reading

Business

Bexil Investment Trust: A Deeply Discounted Fund Without An Escape Hatch (OTCMKTS:BXSY)

Published

on

U.S. Equities: What's Hiding Beneath The Market's Headline Returns?

This article was written by

Rubicon Research is an independent long/short equity analyst and investor who focuses on finding deep value and GARP in equities, as well as event-driven special situations. Investment Philosophy: We practice a mix of expectation investing and gauging market psychology as the main tools for our investment decisions. A stock’s price implies a certain expectation for the company. We take a long or short position when the expectation diverges too much from what we believe to be the fundamental value of a company.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

Charter Communications: Keep Adding On The Way Down

Published

on

Charter Communications: Keep Adding On The Way Down

Charter Communications: Keep Adding On The Way Down

Continue Reading

Business

AvePoint: Stock Set For Gains On Strong Growth And Reasonable Valuation (NASDAQ:AVPT)

Published

on

AvePoint: Stock Set For Gains On Strong Growth And Reasonable Valuation (NASDAQ:AVPT)

This article was written by

David focuses on growth & momentum stocks that are reasonably priced and likely to outperform the market over the long-term. He is a long term investor of quality stocks and uses options for strategy. David told investors to buy in March 2009 at the bottom of the financial crisis. The S&P 500 increased 367% and the Nasdaq increased 685% from 2009 through 2019. He wants to help make people money by investing in high-quality growth stocks.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

The article is for informational purposes only (not a solicitation or recommendation to buy or sell stocks). David is not a registered investment adviser. Investors should do their own research or consult a financial adviser to determine what investments are appropriate for their individual situation. This article expresses my opinions, and I cannot guarantee that the information/results will be accurate. Investing in stocks involves risk and could result in losses.

Advertisement

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Continue Reading

Business

Opinion: The protein of ageing gracefully

Published

on

Opinion: The protein of ageing gracefully

OPINION: The world’s ageing population offers a unique opportunity for producers when it comes to meeting consumer needs.

Continue Reading

Business

Tesla: The Real Problem Is A Rapidly Deteriorating EV Business (NASDAQ:TSLA)

Published

on

Tesla: The Real Problem Is A Rapidly Deteriorating EV Business (NASDAQ:TSLA)

This article was written by

I have more than 35 years of experience in the investment field, having worked as a sell &amp buy side analyst and portfolio manager for debt and equity funds. I am currently managing a high-yield Latam bond fund.My goal, as a Seeking Alpha contributor, is to provide a fundamental view and analysis of companies and funds in a streamlined version of institutional research. The operating and financial forecast, whether my own or based on consensus, drives the valuation and ultimate rating. I like numbers (financial statements) and use words to explain their meaning and potential consequences.For the most part, my selection choices reflect what I believe can offer long-term potential, and I frequently take positions in many ideas for my personal account.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

IDFC First Bank shares soar 9% after Q1 profit jumps 132% to Rs 1,075 crore. What are analysts saying?

Published

on

IDFC First Bank shares soar 9% after Q1 profit jumps 132% to Rs 1,075 crore. What are analysts saying?
Shares of IDFC First Bank rallied as much as 9% to Rs 88 on the BSE on Monday after the lender reported its highest-ever quarterly profit after tax (PAT) of Rs 1,075 crore for the quarter ended June 30, 2026. The profit jumped 132.4% year-on-year (YoY) from Rs 463 crore in the corresponding quarter last year.

The bank, however, disclosed that it received claims worth Rs 514.8 crore under the CGFMU scheme against its MFI portfolio during the quarter.

Net interest income (NII) rose 21.1% YoY to Rs 5,972.3 crore from Rs 4,933 crore a year earlier. The bank’s net interest margin (NIM) also improved to 5.96% in Q1 FY27 from 5.71% in Q1 FY26, marking an expansion of 25 basis points. On a sequential basis, NIM increased by 3 basis points.

Also Read | Costs and provisions down, IDFC Bank will continue to bolster earnings: V Vaidyanathan, MD & CEO

Advertisement

Asset quality showed further improvement. Gross non-performing assets (NPA) fell to 1.51% as of June 30, 2026, from 1.97% a year earlier, an improvement of 45 basis points. Gross NPA also declined by 10 basis points on a quarter-on-quarter basis.

IDFC Bank share price target

Emkay maintained its ADD rating with a target price of Rs 85 (5% upside) per share. It said PAT surged 132% YoY to Rs 1,080 crore, crossing the Rs 21,000 crore mark for the first time, driven by higher NII, strong fee income and lower provisions. Emkay expects positive operating jaws and lower provisioning to support an improvement in ROA over the next few years.
Motilal Oswal maintained its Neutral rating with a target price of Rs 90 per share, implying an 11% upside. The brokerage said IDFC First Bank delivered a strong quarter, supported by healthy operating performance and improved asset quality, aided by one-off interest on an IT refund and strong treasury gains.
Adjusted NIM declined 3 bps QoQ to 5.9%, with management expecting further contraction during the year and guiding for an NIM of 5.8%. Deposit growth remained healthy, driven by strong traction in CASA deposits and higher certificates of deposits, while loan growth was strong, supported by steady momentum in retail and a pick-up in wholesale segments.

Also Read |
Nifty’s 5-day fall may be nearing a reversal; Anand James maps key levels for this week

Management commentary

The lender said it remains focused on building a high-quality banking institution with strong governance standards and is seeing healthy business momentum.

Management said asset quality continued to strengthen, with gross NPA at 1.51% and net NPA at 0.44%. Provisions as a percentage of loans also continued to decline. During the quarter, the bank received a CGFMU claim of Rs 515 crore and, as a prudent measure, created a provision of Rs 515 crore to account for any potential impact from monsoon conditions or fuel price volatility during the rest of the year.

Advertisement

Managing Director and CEO V Vaidyanathan said that investments made in building the bank are now beginning to translate into operating leverage, supporting the rise in PAT to Rs 1,075 crore in Q1 FY27. Return on assets (ROA) also crossed 1%.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)

Continue Reading

Business

Hindustan Zinc shares gain 2% as Q1 net profit soars 145% YoY. Should you buy, sell or hold?

Published

on

Hindustan Zinc shares gain 2% as Q1 net profit soars 145% YoY. Should you buy, sell or hold?
Shares of Hindustan Zinc rose 2% to their day’s high of Rs 541 on the BSE on Monday as multiple brokerages reiterated their ‘Buy’ calls for the Vedanta Group company after it reported a whopping 145% year-on-year (YoY) surge in net profit to Rs 5,469 crore for the first quarter of FY27.

Hindustan Zinc, India’s largest producer of silver, on Friday released its results for the April-June quarter of the ongoing financial year 2027. Its revenue from operations rose around 77% YoY to Rs 13,747 crore during the quarter under review, from Rs 7,771 crore reported in the same period last year. Total expenses increased over 33% YoY to Rs 6,749 crore during the quarter, which ended on June 30, 2026.

The Vedanta Group company’s net profit margin improved to 40% in the April-June quarter of FY27, from 37% in the previous quarter (Q4 FY26) and 29% in the year-ago period (Q1 FY26). Operating margin, meanwhile, increased to 52% during the quarter under review.

The metal major’s net worth also more than doubled on a YoY basis, rising around 108% to Rs 23,587 crore at the end of the June quarter of the ongoing financial year 2027. Its debt-to-equity ratio stood at 0.32 times, as against 1.19 times in Q1 FY26.

Advertisement

Nuvama on Hindustan Zinc share price

Nuvama Institutional Equities noted that Hindustan Zinc’s Q1 EBITDA of Rs 7,990 crore was nearly in line with estimates amid higher prices, partly offset by seasonally lower volume. . Refined Zinc cost of production (ex-royalty) stood lower at $851/ton (down $52/ton QoQ) amid benefits of higher sulphuric acid prices and rupee depreciation, it said.

Silver EBIT was down 2% sequentially due to lower volume and comprised 46% of EBIT in Q1, the brokerage added. “The tight supply market is likely to keep zinc prices relatively high while silver prices are likely to remain firm. We forecast a 3% volume CAGR for refined metal and a 4% volume CAGR for silver over FY26–28E. Higher prices and cost control shall drive EBITDA at 20% CAGR over FY26–28. The 250ktpa zinc smelter expansion shall be commissioned by Q2 FY29,” it added.


Nuvama has a ‘Buy’ call on the shares of Hindustan Zinc with a target price of Rs 700 per share, implying around 32% upside potential from the stock’s previous closing price of Rs 531.95 apiece.

Also read |
Hindustan Zinc names Amarendu Prakash as new CEO; quarterly profit more than doubles on strong metal prices

JM Financial on Hindustan Zinc share price

JM Financial said Hindustan Zinc’s Q1 EBITDA beat its estimate, driven by lower cost of production. “We remain positive on HZL given its industry-leading cost position, strong balance sheet and long-term growth pipeline,” it said.
The domestic brokerage maintained its ‘Buy’ call on the stock with a target price of Rs 660 apiece, implying 24% upside potential.

Motilal Oswal on Hindustan Zinc share price

Motilal Oswal Financial Services said Hindustan Zinc delivered a slight beat on estimates, with revenue growth being driven by favorable commodity prices, higher by-product realization, and a stronger dollar.
EBITDA’s beat on forecast was primarily driven by favorable metal prices and lower cost of production. “Hindustan Zinc continues to report strong earnings, primarily driven by favorable metal pricing and better grades. The company continues to focus on increasing production output with tighter cost-control measures, which could lead to margin sustenance. The recently announced expansion plans are aligned with its long-term objective of doubling existing capacity and enhancing long-term earnings visibility. Although near-term earnings growth is capped due to limited capacity headroom, the LME/silver price inflation emerges as the key catalyst for incremental upside in the near term. We maintain our FY27/28 estimates and believe further price volatility could remain a potential risk or reward for earnings visibility,” it added.

Advertisement

Motilal Oswal however noted that the current valuation has priced in all the positive factors. It reiterated its ‘Neutral’ call on the stock with a target price of Rs 570 apiece.

Also read | Hindustan Zinc Q1 Results: Net profit spikes 145% YoY to Rs 5,469 crore, revenue jumps 77%

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

Advertisement
Continue Reading

Trending

Copyright © 2025